Experimental Weight-Loss Drug Shows Surgery-Like Results in New Trial
Pharmaceutical company Eli Lilly last week the latest data from a phase III trial of its experimental type 2 diabetes and obesity drug, tirzepatide: People who took the drug lost up to 22% of their body weight and achieved far greater weight loss on average than the placebo group.
https://gizmodo.com/tirzepatide-weight-loss-drug-eli-lilly-trial-results-1848887325
